http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-556613-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
filingDate | 2006-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c800cdb29ab0c6292014ef005b9532f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a76ae893176083c00644386f7fdbdc57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb53a00f86af5aacac02fb98e2613728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06cdc99167fa0bb191bd63dd5bf3fcf4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e055701d618f48d5e16ef373369198c8 |
publicationDate | 2010-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | NZ-556613-A |
titleOfInvention | Substituted pyridine derivatives |
abstract | Disclosed are morpholin substituted pyridine amide and ester compounds of formula (I). The substituents are as disclosed in the description. The compounds are suitable for increasing ion flow in a potassium channel. Also disclosed is the pharmaceutical composition and the use of the compounds to treat the central nervous system, seizure disorders, anxiety disorders, neuropathic pain and migraine pain disorders, neurodegenerative disorders, stroke, cocaine abuse, nicotine withdrawal, ethanol withdrawal and tinnitus, acute seizures, convulsions, status epilepticus, epilepsy such as epileptic syndromes and epileptic seizures anxiety and disorders and diseases related to panic attack, agoraphobia, panic disorder with agoraphobia, panic disorder without agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia and other specific phobias, obsessive-compulsive disorder, pos-traumatic stress disorder, acute stress disorders, generalized anxiety disorder, anxiety disorder due to general medical condition, substance-induced anxiety disorder, separation anxiety disorder, adjustment disorders, performance anxiety, hypochondriacal disorders, anxiety disorder due to general medical condition and substance-induced anxiety disorder allodynia, hyperalgesic pain, phantom pain, neuropathic pain related to diabetic neuropathy, neuropathic pain related to trigeminal neuralgia and neuropathic pain related to migraine, Alzheimer's disease, Huntington's chorea, multiple sclerosis, amyotrophic lateral sclerosis, Creutzfeld-Jakob's disease, Parkinson's disease, encephalopathies induced by AIDS or infection by rubella viruses, herpes viruses, borrelia or unknown pathogens, trauma-induced neurodegenerations, neuronal hyperexcitation states such as in medicament withdrawal or intoxication and neurodegenerative diseases of the peripheral nervous system such as polyneuropathies and polyneuritides, bipolar disorders, sleep disorders and insomnia. |
priorityDate | 2005-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 334.